Bioactivity:

Balixafortide TFA (POL6326 TFA) is a selective, well-tolerated peptidic CXCR4 antagonist (IC50 < 10 nM). It shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide TFA blocks _-arrestin recruitment and calcium fl

CAS nr:

TP2141

Purity:

98%

Molecular Weight:

1896,05

SMILES:

Formula:

C82H113N22F3O23S2

Pathway:

Autophagy,Immunology/Inflammation,GPCR/G Protein

Target:

CXCR,CXCR,CXCR